Job Summary

• This role serves as the 'CEO' of the asset, accountable for the strategic leadership and execution of multiple global oncology therapeutic candidates.
• The position requires leading teams from preclinical candidate selection through proof of concept to Phase III investment decisions across diverse biological mechanisms.
• AstraZeneca offers a competitive base pay ranging from $246,069.60 to $369,104.40 along with short-term incentives, equity programs, and comprehensive health benefits.

Matching Summary

Salary

Base: $246,069.60 - $369,104.40; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program eligible; Benefits: 401(k), paid vacation, holidays, medical, dental, vision coverage

Skills & Requirements

Key Requirements

• Graduate degree (PhD, PharmD, or MD/PhD)
• 10+ years leading oncology drug development
• Demonstrated success in early phase non-clinical and clinical development
• Strong regulatory knowledge in oncology

Work Rights